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Metabolic Features of Mouse
and Human Retinas: Rods versus Cones,
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SUMMARY
Photoreceptors, especially cones, which are enriched in the human macula, have
high energy demands, making them vulnerable to metabolic stress. Metabolic
dysfunction of photoreceptors and their supporting retinal pigment epithelium
(RPE) is an important underlying cause of degenerative retinal diseases. Howev-
er, how cones and the macula support their exorbitant metabolic demand and
communicate with RPE is unclear. By profiling metabolite uptake and release
and analyzing metabolic genes, we have found cone-rich retinas and human mac-
ula share specific metabolic features with upregulated pathways in pyruvate
metabolism, mitochondrial TCA cycle, and lipid synthesis. Human neural retina
and RPE have distinct but complementarymetabolic features. Retinal metabolism
centers on NADH production and neurotransmitter biosynthesis. The retina
needs aspartate to sustain its aerobic glycolysis and mitochondrial metabolism.
RPE metabolism is directed toward NADPH production and biosynthesis of
acetyl-rich metabolites, serine, and others. RPE consumes multiple nutrients,
including proline, to produce metabolites for the retina.
INTRODUCTION
Retinal photoreceptors need an enormous supply of ATP, reducing equivalents and other metabolites to
maintain visual transduction and renew their daily-shed outer segments (Hurley et al., 2015; Leveillard and
Sahel, 2017; Okawa et al., 2008). Mutations of metabolic genes or defects in metabolic processes have a
role in many common degenerative retinal diseases such as inherited retinal degeneration, diabetic reti-
nopathy, and age-related macular degeneration (AMD) (Ferrington et al., 2020; Leveillard and Sahel,
2017; Narayan et al., 2017).
Like tumors, retinas are known for aerobic glycolysis, also called the Warburg effect (Hurley et al., 2015).
Aerobic glycolysis can produce large amounts of lactate from glucose, even in the presence of O2. It is esti-
mated that 80%–96% of glucose in isolated retinas is converted into lactate and only a small fraction is
oxidized in the mitochondria (Hurley et al., 2015). Recent studies confirm that mammalian retinas strongly
express enzymes associated with theWarburg effect such as theM2 isoform of pyruvate kinase, hexokinase
2, and lactate dehydrogenase A (Casson et al., 2016; Lindsay et al., 2014; Petit et al., 2018; Rajala et al., 2013;
Rueda et al., 2016). However, retinas are also densely packed with mitochondria, which consume oxygen
rapidly (Hoang et al., 2002; Narayan et al., 2017). Since glucose is the putative primary nutrient for the
retina, it remains unclear how the retina supports its active mitochondrial metabolism while converting
most of its glucose to lactate.
Rods and cones are the two major types of photoreceptors in the retina. Rods are responsible for dimly lit
vision, whereas cones are for high acuity, central vision, and color vision. Cones are highly enriched in the
center of the retina, called the macula, in humans and some birds. Cone photoreceptor degeneration is the
ultimate cause of clinically significant vision loss in conditions such as AMD (Hoang et al., 2002; Narayan
et al., 2017). Cones expend more energy than rods (Johnson et al., 2007; Perkins et al., 2003), but we still
know very little about their metabolism compared with rods. The study of cone metabolism is challenging,
since cones account for only 2%–3% of photoreceptors in mice and rodents do not have the macula. The




University, WVU Eye Institute,
One Medical Center Dr, PO








3Save Sight Institute, Sydney
Medical School, University of





College of Medicine, Bronx,
NY 10461, USA
5Department of Genetics,
Albert Einstein College of









iScience 23, 101672, November 20, 2020 ª 2020 The Author(s).




rod development (Daniele et al., 2005; Mears et al., 2001), and cone-rich human retinal organoids (Kim
et al., 2019) facilitate cone research. To investigate cone photoreceptor metabolism, we used all-cone
mice, cone-rich retinal organoids, and human macula from postmortem donors in this study.
Photoreceptors rely onmetabolic support from their neighboring retinal pigment epithelium (RPE). Disrup-
tion of RPEmetabolism contributes to photoreceptor degeneration (Ferrington et al., 2020; Fisher and Fer-
rington, 2018). Inhibition of RPE mitochondrial metabolism is sufficient to cause AMD-like retinal degener-
ation in mice (Han et al., 2020; Kurihara et al., 2016; Zhao et al., 2011). Conversely, impairment of
photoreceptor metabolism also influences RPE health (Brown et al., 2019). Accumulating evidence sup-
ports the concept that photoreceptors and RPE form an interdependent metabolic ecosystem (Bisbach
et al., 2020; Brown et al., 2019; Kanow et al., 2017; Reyes-Reveles et al., 2017; Wang et al., 2019). Photore-
ceptors shed lipid-rich outer segment discs and export lactate due to theWarburg effect; the RPE converts
the outer segment discs into ketone bodies to fuel photoreceptors and it utilizes lactate to preserve
glucose for photoreceptors(Adijanto et al., 2014; Reyes-Reveles et al., 2017). We have also reported that
reductive carboxylation (reversed TCA cycle) is a very active metabolic pathway in RPE, which it prefers
to fuel with proline (Chao et al., 2017; Du et al., 2016). Proline-derived intermediates, including citrate,
glutamate, and aspartate, can be exported by RPE to fuel retinal mitochondria (Yam et al., 2019). However,
most of these studies come from cultured RPE cells andmice. Native human RPE aremore dense andmulti-
nucleated in the macula than in the periphery (Rashid et al., 2016; Starnes et al., 2016). The macular RPE is
where AMD starts, but the metabolic differences between the RPE of the macula and the peripheral retina,
and their symbiotic relations with the corresponding neural retinal regions, are still unknown.
We used a targeted metabolomics approach in this study to analyze consumed and releasedmetabolites in the
media from cone-rich human retinal organoids, rod-dominant versus all-cone mouse retinas, human macular
versus peripheral neural retinas, and human macular versus peripheral RPE/choroid. By integrating our results
with the analysis of the expression of metabolic genes, we have identified key metabolic features of retinal or-
ganoid development, rods versus cones, macula versus periphery, and neural retina versus RPE. These features
may elucidate the different metabolic needs of retinal mitochondria, cones, and human macula and reveal the
metabolic communications between human retina and RPE at the macula and peripheral retina.
RESULTS
Metabolite Consumption and Metabolic Gene Expression in Human Cone-Rich Retinal
Organoids
Cell differentiation in retinal organoids largely recapitulated transcriptomic and electrophysiological prop-
erties of retinogenesis in vivo (Kim et al., 2019). Retinal organoids at D56 were mainly composed of retinal
progenitor cells and early differentiated retinal cells, whereas retinal organoids at D296 were mostly
composed of maturing cones, rods, and Müller glial cells (Kim et al., 2019). To study the nutrient needs dur-
ing the development of the human retina, we collected spent media 48 h after the medium change from
human retinal organoids on 56 days (D56) and 296 days (D296) (Figure 1A). Blank media without cells in
the same culture plate for 48 h served as baseline control. We targeted 219 metabolites covering major
nutrients and pathways (Table S1) and detected 89 metabolites from these media. To determine metabo-
lite uptake and release, we divided the ion abundance from organoids by those from the control media (see
details in Transparent Methods). Retinal organoids at both D56 and D296 consumed glucose, cystine, and
cystathionine (Figures 1B and 1C). Retinal organoids at D56 used L-Alanyl-Glutamine (GlutaMAX), hypo-
xanthine, lysine, hippurate, glycerol, and biotin, but D296 did not (Figures 1B–1D). Surprisingly, retinal or-
ganoids at D296 consumed 6- to 8-fold more aspartate and glutamate from the media, but organoids at
D56 did not use them at all (Figures 1B and 1C). These results indicate that the consumption of aspartate
and glutamate is specific for mature retinal cells. Additionally, retinal organoids at D296 also consumed
histamine. Glucose can be metabolized through glycolysis and the mitochondrial TCA cycle into lactate,
pyruvate, and other mitochondrial intermediates. GlutaMAX could be hydrolyzed into glutamine and
alanine. As expected, the products from glucose andGlutaMAX, including lactate, pyruvate, alanine, gluta-
mine, proline, citrate, and other metabolites, were produced significantly by D56 organoids (Figure 1E).
D296 organoids generated similar amounts of lactate and pyruvate as D56 organoids, but they produced
11-fold of hypotaurine and 2-fold of acetyl-carnitine (C2-carnitine) (Figures 1F and 1G).
Small molecule transporters and metabolic enzymes contribute to specific profiles in metabolite uptake
and release. To compare the expression of transporters and enzymes, we curated 2,764 classic metabolism
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Figure 1. Metabolite Consumption and Metabolic Gene Expression in Human Cone-Rich Retinal Organoids
(A) Schematic for profiling medium metabolites in retinal organoid culture. Retinal organoids on Day 56 (D56) and D296
were cultured in a medium (see Transparent Methods) for 48 h. The spent media were analyzed for metabolite
consumption or release, and the medium in culture wells without retinal organoids was used as a control.
(B–D) Metabolite consumption in retinal organoids. Metabolite uptake in retinal organoids at (B) 56 days and (C) 296 days.
(D) The comparison of metabolite uptake between D56 and D296 retinal organoids. Data were relative ion abundance
over the control. N = 3, *p < 0.05 versus Control or D56 organoids. Data are represented as mean G SEM. t test.
(E–G) Metabolite release from organoids. Metabolite release in retinal organoids at (E) 56 days and (F) 296 days. (G) The
comparison of metabolite release between D56 and D296 retinal organoids. Data were relative ion abundance over the
control. N = 3, *p < 0.05 versus Control or D56 organoids. Data are represented as mean G SEM. t test.
(H) A schematic of nutrient uptake and release in retinal organoids. Increased metabolites in mature organoids at D296
are colored in red and increased metabolites in D56 organoids are colored in green.
(I) Heatmap of gene expression of top-ranked small molecule transporters in the human retinal organoids cultured at 1-, 3-
, 6-, and 9-month stages. FPKM values of bulk RNA sequencing (Kim et al., 2019) was used for plotting.
See also Figure S1 and Tables S2, S3, and S6.
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genes from KEGG pathways (Table S2) and analyzed their expression in the transcriptome of retinal orga-
noids at stages between 1 and 9 months (Kim et al., 2019). Differentially expressed genes along the time
course of human retinal organoids identified previously (Kim et al., 2019) were intersected with the genes
in metabolic pathways, resulting in 378 metabolic genes that were differentially expressed during the
development of retinal organoids. More than half of the differentially expressed genes were ion and small
molecule transporters (Figure S1A, Table S3). Remarkably, glutamate and aspartate transporters including
solute carrier 1A3 (SLC1A3), SLC17A7, SLC1A7, and SLC1A2 were the most highly enriched of the upregu-
lated small molecule transporters in 9-month organoids (Figure 1H and Table S3). These results indicate
that mature retinal organoids need more aspartate and glutamate. Other amino acids, bicarbonate, and
water transporters were also upregulated in the maturing organoids. Glucose transporter 1 (SLC2A1),
the major glucose transporter, was expressed similarly during organoid development except for a
decrease at 3 months. Monocarboxylate transporter (MCT) is the major lactate/pyruvate transporter in
the retina, and MCT4 or SLC16A3 was expressed similarly between 3- and 9-month organoids (Figure 1H).
These results were consistent with our metabolite consumption data on glucose and lactate. Glutamate
decarboxylase 1 and 2 (GAD1/2) convert glutamate into 4-aminobutyrate (GABA) (Figure 1I). They were
highly upregulated in D296 organoids (Figure S1B), providing further evidence of the need for glutamate.
GABA transporters were also increased in the mature organoids (Table S3). Genes in cysteine, cystathio-
nine, glutathione, and histidine/histamine metabolism were highly enriched in the mature organoids (Fig-
ure S1B). This may implicate in the changed consumption of cysteine derivatives such as cystine, hypotaur-
ine, and histamine. Apart from aspartate and glutamate metabolism, most upregulated genes in mature
retinal organoids were involved in glycan, glycolysis, lipids, ATP-binding cassette (ABC) transporter (lipid
transporter), and nucleotides, especially cyclic nucleotides and purine degradation (Figures S1C–S1E, Ta-
ble S3). Increased purine degradation and recycling may be the cause of the reduced consumption of hy-
poxanthine that we observed (Figures 1D and 1I). To sum up, retinal organoids showed distinctive features
of nutrient consumption and developmentally regulated expression of metabolic genes. Mature retinal or-
ganoids may import and utilize aspartate and glutamate through their upregulated transporters for neuro-
transmitter synthesis and energy metabolism (Figure 1I).
Metabolite Consumption and Metabolic Gene Expression of Rod-Dominant and All-Cone
Mouse Retinas
Rods comprise97% of photoreceptors in mouse retinas. Knockout (KO) ofNrl converts all rods into cone-
like photoreceptors (Mears et al., 2001) to make all-cone retinas. We cultured retinas from 1-month-old
Nrl-heterozygous (Het) (rod-dominant similar to wild type [WT]) mice and Nrl KO mice in transwells and
analyzed metabolites in the media after culturing for 24 h (Figure 2A). Compared with the control media,
32 metabolites fromNrlHet and 37metabolites fromNrl KOmedia were significantly different (Figures 2B–
2H). Most changed metabolites were in a similar pattern in the Het and KO retinas. Interestingly, aspartate
and glutamate were among themost consumedmetabolites in both Het and KO retinas, with a decrease of
8- to 11-fold compared with baseline media (Figures 2B and 2C). Additionally, both Het and KO retinas
consumed glucose, amino acids, carnitine, and intermediates in mitochondrial metabolism including cit-
rate, succinate, and fumarate (Figures 2B and 2C). Like retinal organoids, mouse retinas excreted large
amounts of lactate, acetylcarnitine, and 1-methyladenosine (Figures 2E and 2F). However, mouse retinas
also released nucleosides, other acyl-carnitines, amino acids, and derivatives from amino acids such as cre-
atine and creatinine (Figures 2E and 2F). Isopentenyl pyrophosphate (IPP), an intermediate of the mevalo-
nate pathway, was not detected in the control media but was significantly increased in the spent media of
mouse retinas, especially theNrl KO group (Figure 2G). These results indicate that mouse retinas have very
active mitochondrial, lipid, and nucleotide metabolism.
Twelve metabolites were different between Het and Nrl KO retinas (Figures 2D and 2G–2H). Nrl KO
consumed more pyruvate and cystathionine and produced more lactate, acylcarnitines, creatine, and 1-
methyladenosine (Figures 2D, 2G–2H). In contrast to retinal organoids, neither Nrl Het nor KO retinas
excreted hypotaurine; however, mouse retinas exported more taurine, particularly the Het retinas (Fig-
ure 2H). Ketone bodies are important alternative fuels for neurons. Intriguingly, only rod-dominant retinas
produced the ketone body, 3-HB (Figures 2E–2H), suggesting that there might be interdependent ketone
body utilization between rods and cones.
We then analyzed the expression of metabolic genes from a transcriptome database of WT andNrl KO ret-
inas (Brooks et al., 2011). Among themost abundant small molecule transporters ranked by eitherWT or KO
ll
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Figure 2. Metabolite Consumption and Metabolic Gene Expression in Nrl Het (Rod-Dominant) and Nrl KO (all-
cone) Mouse Retina
(A) Schematic for profiling medium metabolites in mouse retinal explants. Retinas from Nrl Het and Nrl KO mice were
dissected, placed in transwells, and maintained in culture for 24 h. The culture media without retinas were the baseline
control. All media metabolites were analyzed by targeted metabolomics.
(B–D) Metabolite consumption from mouse retinal explants. Metabolite uptake in (B) Nrl Het and (C) Nrl KO retinas. (D)
The comparison of metabolite uptake between Nrl Het and Nrl KO retinas. Data were relative ion abundance over the
control or Nrl Het. N = 6, *P < 0.05 versus Control or Nrl Het retinas. Data are represented as mean G SEM. t test.
(E–H) Metabolite release from mouse retinal explants. Metabolite release in (E) Nrl Het and (F) Nrl KO retinas. (G and H)
The comparison of metabolite uptake between Nrl Het and Nrl KO retinas. Data were relative ion abundance over the
control orNrl Het or absolute ion abundance when those metabolites were not detected in the baseline control. N = 6, *P
< 0.05 versus Control or Nrl Het retinas. Data are represented as mean G SEM. t test.
(I) Gene expression of the top 20 abundant small molecule transporters in the Nrl KO and Het mouse retinas.
(J) Schematic of nutrient uptake and release in Nrl KO retinas. Metabolites with enhanced uptake or release in Nrl KO
retinas are colored red. Upregulated genes in Nrl KO are colored brown. Glu/Asp represents transporters for glutamate
and aspartate.
See also Figures S2–S3 and Tables S2, S4, S7, and S10.
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retinas, transporters for glutamate and aspartate were among the most enriched (Figures 2I and S2). In
particular, Slc17a7 had more abundant transcripts than the other small molecule transporters (Figures 2I
and S2). Transporters for glucose, GABA, glutamine, lactate, pyruvate, and ketone bodies were also among
the top transporters. Compared with WT, 800 metabolic genes were changed, with 401 upregulated in Nrl
KO retinas (Figure S3, Table S4). Ion transport, lipid metabolism, small molecule transport, glycan, amino
acid, nucleotide, and sugar metabolism were the major changed pathways (Figure S3). Key enzymes in
glycogen metabolism (Pygm, Gaa), pyruvate metabolism (Pcx, Pdha1, Me1), TCA cycle (Cs, Acly, Ogdh,
Idh3a), cysteine/cystathionine metabolism (Suox, Ado, Cdo1, Gclm), and fatty acid synthesis (Acaca,
Acacb, Oxsm, Elovl6) were significantly upregulated in Nrl KO retinas (Figures 2J and Table S4). These
data support the nutrient uptake and release results, indicating that cone photoreceptors require more py-
ruvate and other nutrients for their robust mitochondrial TCA cycle, lipid synthesis, and amino acid meta-
bolism (Figure 2J).
Metabolite Consumption and Metabolic Gene Expression of Human Peripheral and Macular
Retina
To investigate the nutrient utilization of the humanmacula and peripheral retina, we cultured human neural
retinal explants punched from themacular and peripheral regions from the same donor (Figure 3A). Human
donors had no known retinal diseases, and postmortem fundus photographs showed no abnormalities
(Figures 3A and Table S5). After culturing for 24 h, media levels of 52 metabolites in the peripheral retina
and 51 metabolites in the macula were significantly different (Figures 3B–3H and S4). Strikingly, aspartate
and glutamate were almost completely depleted in spent media from both peripheral retina and macular
punches (Figures 3B and 3C). Aspartate and glutamate were supplemented at0.15 mM in all the media of
retinal cultures, and they were depleted in mature retinal organoids, mouse retinas, and human retinas (Ta-
bles S6–S8). These findings demonstrate that retinas need substantial amounts of aspartate and glutamate.
As well as glucose, carnitine, and amino acids, human retinas also actively consumed vitamins such as pan-
tothenic acid, nicotinamide, and biotin (Figures 3B–3D and S4). b-Alanine, which can be metabolized into
acetyl-CoA in mitochondria, was also reduced 2- to 3-fold in the media. Similar to mouse retinas, both mac-
ular and peripheral retinas released lactate, nucleosides, and acylcarnitines, confirming that human retinas
are very active in metabolizing glucose, amino acids, and lipids (Figures 3E–3G and S4). Creatine, creati-
nine, and citrulline increased 3- to 7-fold in the media with retinal cultures (Figures 3E–3G). These metab-
olites, synthesized from arginine, are involved in the synthesis and degradation of the high-energy metab-
olite phosphocreatine. IPP, guanosine, kynurenine, and N1-methylnicotinamide were not detected in the
control media but significantly increased in spent media from both macular and peripheral neural retinas
(Figure 3G). These results confirm that the mevalonate pathway, purine catabolism, and NAD metabolism
are active in the retina.
Twenty-five metabolites in the media were significantly different between the macular and the peripheral
retina (Figures 3D and 3G–3H). In general, the neural macula consumed and released more metabolites
than the peripheral retina except for succinate, betaine, and kynurenine (Figures 3D and 3G–3H). Like
cone-dominant Nrl KO retinas, the neural macula consumed more pyruvate from the media and released
more lactate, acetylcarnitine, 1-methyladenosine, and creatine into the media. These data suggest that the
neural macula has more active energy metabolism than the peripheral retina. In support of this, the neural
macula released more nucleosides and several TCA cycle intermediates than the peripheral retina
(Figure 3H).
To further understand the genetic basis for this differential nutrient consumption, we analyzed the expres-
sion of metabolic genes in a human transcriptome database (Whitmore et al., 2014). As in the mouse ret-
inas, aspartate and glutamate transporters were highly enriched among the most abundant small molec-
ular transporters in both the macula and peripheral retina, with SLC17A7 being the most abundant of all
(Figures 3I and S5). Transporters for glucose, glutamine, taurine, creatine, lactate, and pyruvate were
also among the most abundant transporters (Figures 3I and S5). Metabolic gene analysis found 307 upre-
gulated and 192 downregulated genes in neural macula, compared with peripheral retina (Table S9).
Similar to mouse Nrl KO retinas, the most changed pathways were in ion transport, small molecule trans-
port, lipid, glycan, amino acid, nucleotide, and sugar metabolism (Figure S6). Changed small molecule
transporters were enriched for the transport of sugar, glutathione, glycine, serine, arginine, citrulline,
and glutamate (Figure S6). Glycan, a polysaccharide that conjugates with lipid and protein to make the
cell membrane, is synthesized mostly from glucose and fructose. Strikingly, most genes in glycan synthesis
ll
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Figure 3. Metabolite Consumption and Metabolic Gene Expression in the Human Macular and Peripheral Retina
(A) Schematic diagram of human macular and peripheral explant culture. Macula and Peripheral punches from neural
retinas or their corresponding RPE/choroid punches were cultured on inserts in transwell plates for 24 h. Representative
fundus images from one donor showed healthy retinas. Representative images of cultured macular and peripheral neural
retinas and RPE/choroids in transwell plates.
(B–D) Metabolite consumption from human neural retinal explant culture. Metabolite uptake from (B) peripheral and (C)
macular retinal explants. (D) The comparison of metabolite uptake between macular and peripheral retinal explants. Data
were relative ion abundance over the control or peripheral retinas. N = 8, *P < 0.05 versus Control or peripheral retinas.
Data are represented as mean G SEM. t test.
(E–H)Metabolite release from human neural retinal explant culture. Metabolite release from (E) peripheral and (F) macular
retinal explants. (G and H) The comparison of metabolite release between macular and peripheral retinal explants. Data
were relative ion abundance over the control or peripheral retinas, or absolute abundance when detected in the baseline
control. N = 8, *P < 0.05 versus Control or peripheral retinas. Data are represented as mean G SEM. t test.
(I) Gene expression of the top 20 abundant small molecule transporters in human peripheral and macular retinas.
(J) Schematic of nutrient uptake and release in macular retinas. Metabolites with enhanced uptake or release in macular
retinas are colored red. Upregulated genes in macular retinas are colored brown. Glu/Asp represents transporters for
glutamate and aspartate.
See also Figures S4–S6 and Tables S2, S5, S8, S9, and S10.
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were upregulated in themacula, but genes responsible for its degradation were downregulated, indicating
the neural macula requires more exogenous glucose to meet the high demand for glycans.
Key enzymes in several major metabolic pathways were significantly upregulated in the macula compared
with the peripheral retina such as those responsible for glycogen metabolism (PYGM, PYGB, GBE1, UGP2),
pyruvate metabolism (PC, ME2, LDHB, LDHD), TCA cycle (OGDH, ACLY, MDH1, ACO1, SDHA), fatty acid
synthesis (ACACA, ACSS2, FASN, ELOVL6), mevalonate and cholesterol metabolism (IDI1, HMGCR,
HMGCS1), ketone body metabolism (OXCT2, HMGCLL1), and NAD synthesis (QPRT, NMNAT2) (Table
S9, Figure 3J). These upregulated pathways in human neural macula were similar to all-coneNrl KO retinas.
By comparing the changed metabolic genes in Nrl KO with the human macula, we found 119 of 177 genes
were changed in the same way, including those in the major metabolic pathways (Table S10). These results
indicate that all-cone mouse retinas have some metabolic similarities with the cone-enriched human mac-
ula. Notably, pyruvate was the only nutrient that was consumed more by both Nrl KO retinas and human
macula. Pyruvate carboxylase (PC in human and Pcx in mouse), which utilizes pyruvate for TCA cycle and
gluconeogenesis, was also increased in both Nrl KO retinas and macular retinas (Figure 3J). These data
demonstrate that the neural macula meets its higher metabolic requirements by utilizing more glucose
and pyruvate for the TCA cycle and synthesis of glycan, glycogen, and lipids.
Metabolite Consumption and Metabolic Gene Expression in Human Peripheral and Macular
RPE/Choroid
The RPE, tightly bound to the choroid, is critical to transport metabolites to and from the retinas. To understand
the metabolic communications between retina and RPE, we studied the nutrient uptake and release of punches
of humanRPE/choroid using the samedonor eyes from the neural retinal experiments (Figure 3A). The profiles of
consumption and release by humanRPE/choroid punches frombothmacula and periphery were similar to those
of our previously reported studies of human RPE in vitro (Chao et al., 2017) but quite different from those in hu-
man retinas (Figures 4A–4G and S7). As well as specific nutrients in the media, such as carnitine, nicotinamide,
cysteine, and proline, human RPE/choroid also consumed nutrients not specified in themedium formula such as
N-acetylglycine, erythritol, and succinate (Figures 4A and 4B). These metabolites may come from serum and
other supplements in the media. In contrast to neural retinas, RPE/choroid did not consume glutamate, and
only the macular RPE used a small amount of aspartate (<1.5-fold), confirming that the consumption of gluta-
mate and aspartate is specific to the neural retina. In contrast to human neural retinas, human RPE/choroid
consumed, rather than excreted, taurine and betaine (Figures 4D–4G and S7), suggesting that the neural retina
and RPE might exchange these metabolites.
As well as lactate, nucleosides, and acylcarnitines, RPE/choroid from both macula and periphery exported
considerable amounts of citrate, isocitrate, 3-HB, and cholesterol (Figures 4D and 4E), supporting previous
reports (Adijanto et al., 2014; Reyes-Reveles et al., 2017) that RPE actively metabolizes lipids. Compared
with their corresponding neural retinas, RPE/choroid exported 40 times more N1-methylnicotinamide
(methylated from nicotinamide), indicating that RPE/choroid has highly active nicotinamide catabolism
(Figure 4F). Additionally, RPE/choroid released serine, b-alanine, and glycerol, which were consumed by
the human neural retinas (Figures 4D–4E and S7), providing further evidence for metabolic communication
between the neural retina and the RPE.
The peripheral RPE/choroid punches consumed and released significantly more metabolites than the mac-
ular punches (Figures 4 and S7). However, the macular punches generally consumed or released more of
the changed metabolites that they had in common with the peripheral RPE/choroid punches (Figures 4C
and 4G). The macular RPE/choroid punches utilized more nicotinamide, erythritol, and glucose than their
peripheral counterparts (Figure 4C). Erythritol comes from either additives or endogenous synthesis from
glucose. It can be metabolized into erythronic acid, which is abundant in human aqueous humor (Harding
et al., 1999). RPE/choroid punches from the macular region also released more N1-methylnicotinamide,
malate, b-alanine, and ornithine, which may have been derived from the methylation of nicotinamide
and glucose catabolism (Figures 4F, 4G, and 4I).
Unlike neural retinas, no aspartate/glutamate transporters were found in the top 20 most abundant small
molecule transporters in the RPE/choroid (Figures 4H and S8). The abundance of small molecule trans-
porters was generally higher in the peripheral RPE than the macula, supporting our data that there were
more changed metabolites in the periphery. MCTs for lactate, pyruvate, and ketone bodies and
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Figure 4. Metabolite Consumption and Metabolic Gene Expression in Human Macular and Peripheral RPE/
Choroids
(A–C) Metabolite consumption from human RPE/choroid explant culture. Metabolite uptake from (A) peripheral and (B)
macular RPE/choroid explants. (C) The comparison of metabolite uptake between macular and peripheral RPE/choroid
explants. Data were relative ion abundance over the control or peripheral RPE/choroid explants. N = 8, *P < 0.05 versus
Control or peripheral RPE/choroid explants. Data are represented as mean G SEM. t test.
(D–G) Metabolite release from the macular and peripheral RPE/choroid explant culture. Metabolite release from (D)
peripheral and macular (E) RPE/choroid explants. (F–G) The comparison of metabolite uptake between macular and
peripheral RPE/choroid explants. Data were relative ion abundance over the control or peripheral RPE/choroid explants,
or absolute abundance when detected in the baseline control. N = 8, *P < 0.05 versus Control or peripheral RPE/choroid
explants. Data are represented as mean G SEM. t test.
(H) Gene expression of the top 20 abundant small molecule transporters in human peripheral and macular RPE/choroid.
(I) Schematic of nutrient uptake and release in macular RPE/choroid. Red-colored metabolites are those with increased
uptake or release in macular RPE/choroid. ABC transporters and glucose transporters (SLC5A9 and SLC2A4) are
upregulated in macular RPE/choroid.
See also Figures S7–S9 and Tables S2, S5, S11, and S16.
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transporters for a-ketoglutarate, sugar, leucine, proline, and choline were abundant in peripheral RPE/
choroid (Figures 4H and S8), consistent with the altered uptake and release of these metabolites. The anal-
ysis of expression of metabolic genes found that there were 127 genes that were differentially expressed






















































































































Figure 5. Comparison of Metabolite Consumption and Metabolic Genes between Human Retinas and RPE/
Choroids
(A) Differential metabolite consumption and release between human retinas and RPE/choroids. Metabolites are
colored for changes over their baseline controls. Blue, metabolite consumption; red, metabolite release; and yellow,
unchanged.
(B) Comparing gene expression in major metabolic pathways between human retinas and RPE/choroids.
See also Figures S10–S11 and Tables S12, S13, and S14.
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metabolism, transporters, and amino acid metabolism (Figure S9). Interestingly, genes involved in glycol-
ysis and the TCA cycle were either decreased or unchanged in the macular RPE/choroid, whereas glucose
transporters (SLC2A4, SLC5A9) were significantly increased (Table S11, Figures 4I and S9). Overall, genes in
both lipid synthesis and lipid transporters were upregulated in the macular RPE/choroid punches
compared with those from the peripheral RPE/choroid retina (Figure 4I).
Human Retina and RPE/Choroid Have Distinctive but Symbiotic Metabolic Features
To compare the metabolic features of the human retina and RPE/choroid, we studied the uptake and
release of metabolites in the media from their cultures (Figures 3, 4 and 5A). We found 25 metabolites
were consumed and released in the same pattern between retinas and RPE/choroid such as glucose,


















































































































Figure 6. A Proposed Model of Metabolic Communications between Human Retina and RPE/Choroid
Glucose transports through RPE from the choroid to the retina (bold green line). RPE strongly expresses genes in PPP,
serine de novo synthesis, and one-carbon metabolism, which can use glucose to generate NADPH. The retina strongly
expresses glycolic genes to produce lactate andNADH. The retina imports aspartate and glutamate through upregulated
transporters (bold red line). Aspartate can be converted into OAA and malate to recycle NADH into NAD+ and bring
electrons into mitochondria to produce ATP. Aspartate can also be used for the synthesis of glutamate, asparagine (ASN),
N-acetylaspartate (Asp). The retina needs a large amount of glutamate for neurotransmission, the mitochondrial TCA
cycle, and biosynthesis of GABA, glutathione (GSH), and glutamine (Gln) (bold blue line). RPE mitochondria use different
substrates such as proline (yellow line), BCAAs, and lipids to synthesize NADPH and other metabolites that can be
released to be used by the retina. Cone-rich retinas or human macula consumes more pyruvate (bold black line) for
mitochondrial metabolism. Brown colored genes are upregulated genes in the retinas or RPE.
See also Figure S11.
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by the neural retina, indicating these metabolites are neural retina specific. Sixteen metabolites were
consumed or released only by RPE/choroid, indicating that they are RPE specific (Figure 5A). Interest-
ingly, ten metabolites were consumed or released in opposite patterns, such as serine, ornithine, and
b-alanine (Figure 5A), which were released by RPE/choroid but consumed by the neural retinas, suggest-
ing that retinas and RPE are metabolically interdependent. Overall, we found neural retinas and RPE/
choroid not only share some common pathways but also have their distinctive preferences in nutrient
consumption and production.
About half of the 2,764 metabolic genes we studied were expressed differentially in human neural retinas
versus RPE/choroids: 1,473 in the macula and 1,770 in the periphery (Tables S12 and S13). Transporters,
lipids, glycan, amino acid, nucleotide, and sugar metabolism were again the major altered pathways be-
tween retinas and RPE/choroids (Figure S4). All genes involved in aspartate/glutamate transport and catab-
olism were upregulated in the neural retinas except aspartoacylase, which regenerates aspartate from N-
acetyl-aspartate (Figures 5B and Table S13). This strongly suggests that retinas have a specific requirement
for aspartate and glutamate, as summarized in Figure 6. More transporters for glucose, lactate, and pyru-
vate were found in RPE/choroid but they were also enriched in the retinas, indicating that thesemetabolites
are essential nutrients for both tissues. As expected, neural retinas predominantly expressed genes
involved in glycolysis to support their robust aerobic glycolysis (Figures 5B and S10, Table S14). Interest-
ingly, many mitochondrial TCA cycle genes expressed different isoforms in neural retinas versus RPE/
choroid. For example, NAD+-dependent IDH3A/B, ADP-dependent SUCLA2, ACO2, and L2HGDH were
predominantly expressed in the neural retinas, whereas NADP+-dependent IDH1/2, GDP-dependent
SUCLG2, ACO1, and D2HGDH were mainly expressed in the RPE/choroid (Figure 6, Table S14). Notably,
upregulated TCA cycle genes in the neural retinas were mostly NAD+ dependent. This differential expres-
sion suggests neural retinas and RPE have different roles in mitochondrial bioenergetics and biosynthesis.
Strikingly, NADP(H)-associated pathways, including the pentose phosphate pathway (PPP) and one-carbon
metabolism, were highly upregulated in the RPE/choroid compared with neural retinas (Figure 5B). Genes
in serine synthesis were upregulated in RPE/choroid, but serine transporters were upregulated in the neural
retinas. This was consistent with our findings that serine was released by RPE/choroid and consumed by
retinas (Figures 5B and Table S14). Remarkably, genes involved in proline metabolism and nicotin-
amide/NAD metabolism were significantly upregulated in RPE/choroid, consistent with our findings that
RPE/choroid consumed proline and nicotinamide. Many genes in amino acid metabolism pathways,
such as those for cysteine, taurine, and citrulline, were partly upregulated in neural retinas or RPE/choroids,
further indicating that there are symbiotic metabolic relationships between them (Figure 6).
DISCUSSION
We have compiled an atlas of nutrient consumption and utilization in human retinal organoids, mouse ret-
inas, all-cone mouse retinas of Nrl KO, and human macular and peripheral retinas. By combining nutrient
consumption with metabolic gene analysis, we have identified the following key features of neural retinal
and RPE metabolism (Figure 6).
 Neural retinal metabolism centers on NADH-related metabolism for ATP production and the synthe-
sis of neurotransmitters such as glutamate and GABA. The neural retina consumes glucose, aspar-
tate, glutamate, citrate, nicotinamide, and other nutrients to sustain its active glycolysis, mitochon-
drial oxidative metabolism, and neurotransmitter synthesis.
 Cone-rich retinas and the neural macula have more active glycolysis and mitochondrial metabolism,
through which they consume more pyruvate, than the rod-rich peripheral neural retina.
 Mature retinal organoids have aspartate/glutamate metabolism that is similar to the human neural
retina.
 RPE/choroid metabolism centers on NADPH-related and acetyl-CoA metabolism for biosynthesis.
RPE/choroid consumes glucose, proline, nicotinamide, BCAAs, and other nutrients for its activate
PPP, reductive carboxylation, serine synthesis, one-carbon metabolism, citrate synthesis, ketone
body synthesis, and cholesterol synthesis.
 Neural retinas and RPE/choroid have specific and complementary profiles in nutrient consumption
and production that support their tight metabolic communications.
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Uptake of aspartate and glutamate was a common feature in cone-rich retinal organoids and mouse
and human retinas. Transporters and enzymes responsible for aspartate and glutamate metabolism
were also highly enriched in the retina. Why do retinas actively consume aspartate and glutamate? Aspar-
tate and glutamate are interconvertible by transamination with their ketoacids through GOT1/2 (Figure 6).
We recently also reported that aspartate transamination is the primary pathway for the catabolism of aspar-
tate and glutamate in mouse neural retinas (Xu et al., 2020). As a major neurotransmitter, glutamate is the
most abundant amino acid in the retina (Kalloniatis et al., 1996; Marc et al., 1995). Retinal cells with the high-
est glutamate levels also have the highest aspartate levels (Kalloniatis et al., 1996). We have previously re-
ported that aspartate is utilized robustly to provide both carbons and nitrogen groups for glutamate syn-
thesis (Du et al., 2013; Lindsay et al., 2014; Xu et al., 2020). Notably, aspartate transamination also generates
oxaloacetate (OAA), which can be converted tomalate by cytosolic malate dehydrogenase (MDH1) to carry
electrons into mitochondria through the malate-aspartate shuttle (Figure 6). This is important because it
may help address the paradox of how the retina supports its active mitochondrial metabolism, whereas
its metabolism relies on the Warburg effect that allows only a small proportion of pyruvate to be oxidized.
MDH1 and GOT1 transcripts are more abundant than any other TCA cycle enzymes in both human and
mouse neural retinas (Figure S11), supporting that aspartate catabolism is enhanced in the retina. Aspar-
tate catabolismmay (1) recycle NADH into NAD+ to sustain the highly active glycolysis, (2) provide cytosolic
electrons for ATP production, (3) replenish mitochondrial OAA for biosynthesis, and (4) produce cytosolic
and mitochondrial pyruvate through malic enzymes (Figure 6). Interestingly, low glucose or inhibition of
glucose oxidation could cause massive accumulation of aspartate in the neural retina with severe depletion
of glutamate (Du et al., 2013; Grenell et al., 2019; Zeevalk andNicklas, 2000). Therefore, aspartate utilization
supports active glycolysis, mitochondrial metabolism, and glutamate synthesis. Additionally, aspartate is
an immediate precursor for asparagine and N-acetylaspartate (NAA), both of which are important for
neuronal function (Ramos et al., 2011; Ruzzo et al., 2013) (Figure 6). Deficiency of the mitochondrial aspar-
tate/glutamate carrier 1(AGC1) reduces aspartate and NAA, resulting in brain defects and impaired visual
function (Contreras et al., 2016; Jalil et al., 2005; Ramos et al., 2011).
Besides being a neurotransmitter, glutamate is an important substrate for the TCA cycle and the synthesis
of glutamine and glutathione (Figure 6). Decreased glutamate availability substantially reduces the levels
of glutamine and glutathione (Grenell et al., 2019). Glutamate also serves as a major nitrogen donor to syn-
thesize non-essential amino acids by transaminases and is a precursor for GABA by decarboxylation (Fig-
ure 6). Consistently, glutamate alanine transaminase and glutamate decarboxylases are strongly expressed
in the neural retina (Whitmore et al., 2014). Blood levels of aspartate and glutamate are quite low (Dasarathy
et al., 2010; Hui et al., 2017); it remains unclear how they are transported across retina-blood barriers. RPE
may be a source of aspartate and glutamate for the retina. We have reported that RPE can metabolize
glucose and proline into glutamate and aspartate, which are exported to be used by the retina (Chao
et al., 2017; Yam et al., 2019). Notably, glutamate content decreases in cone photoreceptors overlying
RPE defects in atrophic AMD (Jones et al., 2016). There is a moderate expression of multiple transporters
for aspartate and glutamate in the RPE (Whitmore et al., 2014).
Cones are known to have much higher energy needs than rods (Korenbrot, 2012). It is postulated that mito-
chondrial metabolismmay support the extra energy demand, as cones have 2–10 times moremitochondria
and 3 times more cristae membrane surface than rods (Hoang et al., 2002; Perkins et al., 2003, 2004). The
generation of higher lactate, acetylcarnitine, and IPP (synthesized from acetyl-CoA) in both all-cone mouse
retinas and the neural macula, which is cone-rich, provides strong evidence that cones are more metabol-
ically active than rods. We also found all-cone neural retinas and macula consume more pyruvate than the
peripheral neural retina, which is rod dominant. This may explain how cones fuel their abundant mitochon-
dria even when they have active aerobic glycolysis. The SLC16A3 (MCT4), which has low affinity for pyruvate
in order to preserve intracellular pyruvate levels (Bergersen, 2015), is strongly expressed in the neural mac-
ula (Table S9). Inhibition of pyruvate utilization causes visual impairment in mice and fish due to photore-
ceptor degeneration (Grenell et al., 2019; Taylor et al., 2004). Pyruvate provides metabolic advantages that
enhance both glycolysis and mitochondrial metabolism. Pyruvate can regenerate NAD+ through lactate
dehydrogenase to stimulate glycolysis. Mitochondria need a constant supply of acetyl groups from
acetyl-CoA and OAA to synthesize citrate to sustain the TCA cycle for oxidative and biosynthetic meta-
bolism (Figure 6). Pyruvate provides both acetyl groups and OAA through pyruvate dehydrogenase and
PC. The neural retina can also use fatty acids and ketone bodies, but these nutrients only provide acetyl
groups (Joyal et al., 2018; Reyes-Reveles et al., 2017). Consistently, pyruvate carboxylase expression was
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upregulated in both all-cone retinas and neural macula. Hepatic deletion of PC in mice diminishes TCA cy-
cle intermediates, especially aspartate, and depletes NADPH and glutathione (Cappel et al., 2019). PPP is
the classic pathway to generate NADPH for the regeneration of visual pigment, but its activity is very low in
the neural retina and photoreceptors (Adler et al., 2014; Futterman and Kinoshita, 1959; Winkler et al.,
1986). The regeneration of visual pigment in cones is at least 100 times faster than rods (Chen et al.,
2009). Pyruvate could stimulate PPP activity 15 times in isolated neural retinas (Futterman and Kinoshita,
1959) and may contribute to the high demand for NADPH in cones. Pyruvate also increases the availability
of glutamate and glutamine in vitro (Gamberino et al., 1997; Lieth et al., 2001). We have reported that
retinal deletion of the mitochondrial pyruvate carrier leads to the accumulation of pyruvate and aspartate
but the depletion of glutamate, glutamine, and glutathione results in retinal degeneration (Grenell et al.,
2019). Interestingly, pyruvate supplementation prevents light-induced retinal degeneration (Natoli et al.,
2016; Ren et al., 2011; Sato et al., 2020). Further research is warranted to determine whether increasing py-
ruvate utilization by supplementation or genetic approaches might have a neuroprotective effect on the
macula.
The RPE is closely coupled with photoreceptors in nutrient utilization (Han et al., 2020; Kanow et al., 2017;
Reyes-Reveles et al., 2017; Xu et al., 2020). In agreement with other studies of RPE cells (Chao et al., 2017;
Xu et al., 2020; Yam et al., 2019), we found that human RPE/choroid explants consumed glucose, proline,
nicotinamide, and BCAAs and released plenty of 3-HB, citrate, and cholesterol. All these released me-
tabolites are made from acetyl-CoA, indicating that RPE mitochondria function like mitochondria in
the liver that oxidize nutrients to support other tissues. Interestingly, retinas could readily utilize the
released 3-HB, citrate, and cholesterol for bioenergetics and biosynthesis (Chao et al., 2017; Futterman
and Kinoshita, 1959; Grenell et al., 2019; Reyes-Reveles et al., 2017; Tserentsoodol et al., 2006). The
different consumption of metabolites by the neural retina and RPE/choroid suggests an important meta-
bolic coupling between them. For example, RPE released serine, but the retina consumed serine. Serine
is an essential precursor for phospholipid synthesis and one-carbon metabolism. Photoreceptors require
active phospholipid biosynthesis to renew their daily shedding of outer segments, but enzymes for serine
synthesis are highly expressed in RPE (Figure 5B) (Sinha et al., 2020). The uptake of serine by our neural
retinal cultures and upregulated serine transporters sideroflexin 1/3 (SFXN1/3) in the neural retina further
suggest that retinas need exogenous serine. Mutations of SFXN3 leads to progressive outer retinal
degeneration (Chen et al., 2020). Remarkably, low serine from the RPE may account for the synthesis
of toxic deoxysphingolipids in the degenerative macular condition, macular telangiectasia type 2 (Gant-
ner et al., 2019).
In summary, profiling nutrient uptake and release by tissue explants provides a useful platform to investi-
gate tissue-specific and inter-tissue metabolism and to functionally annotate the ever-increasing tissue-
specific metabolic transcriptome. By profiling mouse and human retinal explants, we reveal distinctive
metabolic features in progenitor versus differentiated retinal organoids, mouse rod versus cone-retinas,
and human peripheral neural retina versus the neural macula. These findings provide a resource of basic
information for future studies on the retina and RPE metabolism.
Limitations of the Study
Traditional culture media were used for our organoid and retinal explant culture. These media may not
reflect the microenvironment in vivo. For example, no lactate was included in these media, but RPE in an
eye may be exposed to high amounts of lactate from the neural retina. A recent study showed that RPE
can uptake lactate to preserve glucose for photoreceptors (Kanow et al., 2017). Future investigation of
metabolite concentrations in choroid and vortex veins will be important for developing a medium formu-
lation that more accurately mimics in vivo conditions. Additionally, the glucose concentrations in our cul-
ture were higher than physiological conditions owing to the limitation of traditional static culture. A micro-
fluidic perifusion with a physiological concentration of glucose is under exploration to optimize human
retinal explant culture. Our human RPE explant culture provides information for metabolite uptake and
release, but it cannot be used to study metabolite transport because the RPE explant only covers part of
the transwell membrane and there is no biological barrier between the upper and lower chamber. Human
neural retinal explants cultured together with human RPE cells can be investigated with stable-isotope
tracers to understand metabolite transport and communication between neural retina and RPE. Cone-
like photoreceptors in Nrl KO eyes may still be different from mature cones in wild animals. Future studies
on cone-rich animals such as squirrels, fish, and chicken will help to validate our findings on cone-specific
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metabolism. A limitation of our targeted metabolomics analysis is that we reported the ion abundance, not
absolute abundance. Evaluation of absolute abundance will require labeled internal standard for each
metabolite to avoid matrix effect in the mass spectrometry analyses. Future technical improvements in
our analysis procedure will focus on determining the absolute concentration of many of the keymetabolites
in retinas and RPE. Finally, the human retinas from our explant culture underwent postmortem delay, which
can influence metabolism in these tissues.
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Supplemental Figures
Figure S1. Metabolic genes are temporally expressed in retinal organoids. Related to Figure 1. Differentially
expressed genes along the time-course of human retinal organoids were intersected with the genes in metabolic
pathways, resulting in a list of developmentally regulated metabolic genes. (A) Subgroups of developmentally regulated
metabolic genes. (B-E) Heatmaps showing temporal expression of metabolic genes in (B) amino acid, (C) glycans &
glycolysis, (D) ABC transporter & lipid and (E) nucleotide in human retinal organoids.
Figure S2. Top small molecule transporters ranked by WT retinas. Related to Figure 2. Top 20 most abundant small
molecule transporters ranked by the expression in WT retinas.
Figure S3. Changed metabolic genes in the Nrl KO vs WT retinas. Related to Figure 2. (A) Number of changed
genes in metabolic pathways in Nrl KO retinas. (B-E) Heatmaps of differentially expressed genes in (B) small molecule
transport, (C) glycogen, pyruvate, TCA cycle & glycolysis, (D) amino acid, (E) lipid in Nrl KO retinas.
Figure S4. Metabolite uptake and release in human macular and peripheral retinas. Related to Figure 3. (A)
Uptaked metabolites in the medium from peripheral retina culture. (B) Released metabolites in the medium from
peripheral retina culture. (C) Released metabolites in the medium from macular retina culture. Error bars represent mean
± SEM. N=8, *P<0.05 vs baseline control. t test.
Figure S5. Top small molecule transporters ranked by peripheral retinas. Related to Figure 3. Top 20 most
abundant small molecule transporters ranked by the expression in human peripheral retinas. Periphery expression was
the average of the expression in nasal and temporal regions.
Figure S6. Changed metabolic genes in the macular and peripheral retinas. Related to Figure 3. (A) Number of
changed genes in metabolic pathways. (B-E) Heatmaps of differentially expressed genes in (B) small molecule transport,
(C) glycans, (D) glycogen, pyruvate, TCA cycle & glycolysis, (E) amino acid, (F) fatty acid, mevalonate, cholesterol,
ketone body & NAD metabolism.
Figure S7. Metabolite uptake and release in human macular and peripheral RPE/choroid. Related to Figure 4. (A)
Uptaked metabolites in the medium from peripheral RPE/choroid culture. (B) Released metabolites in the medium from
peripheral RPE/choroid culture. (C). Released metabolites in the medium from macular RPE/choroid culture. Error bars
represent mean ± SEM. N=8, *P<0.05 vs baseline control. t test.
Figure S8. Top small molecule transporters ranked by peripheral RPE/choroid. Related to Figure 4. Top 20 most
abundant small molecule transporters ranked by the expression in human peripheral RPE/choroid. Periphery expression
was the average of the expression in nasal and temporal regions.
Figure S9. Changed metabolic genes in the macular and peripheral RPE/choroid. Related to Figure 4. (A) Number
of changed genes in metabolic pathways. (B-C) Heatmaps of differentially expressed genes in (B) glycolysis, TCA cycle &
ETC, (C) small molecule transport, (D) ABC transporter & lipid.
Figure S10. Changed metabolic genes between human retinas and RPE/choroid. Related to Figure 5. (A) Number
of changed genes in metabolic pathways in the macula. (B). Number of changed genes in metabolic pathways in the
periphery.
Figure S11. The expression of TCA cycle genes in mouse and human retinas. Related to Figure 5-6.
Supplemental Tables
Table S5. Donor information for human retina and RPE/choroid explants. Related to Figure 3-4.
Donor ID Eye (s) Gender Age Post-mortem Delay Known eye diseases
190800 both F 66y 19h No
190820 both M 83y 28h No
190850 both F 77y 24h No
190853 both F 71y 28h No
Table S6. Medium formulation for retinal organoid culture. Related to Figure 1.
Components
Concentration
(mg/L) mM Category Source
Glycine 31.88 0.43 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES + NEAA
L-Alanine 11.12 0.12 Amino Acids DMEM/F-12, HEPES + NEAA
L-Alanyl-Glutamine
(GlutaMAX) 431.00 1.99 Amino Acids DMEM, high glucose, GlutaMAX™
L-Arginine hydrochloride 115.75 0.55 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Asparagine 16.50 0.13 Amino Acids DMEM/F-12, HEPES + NEAA
L-Aspartic acid 16.63 0.13 Amino Acids DMEM/F-12, HEPES + NEAA
L-Cysteine
hydrochloride-H2O 8.78 0.05 Amino Acids DMEM/F-12, HEPES
L-Cystine 2HCl 47.15 0.15 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Glutamic Acid 18.38 0.13 Amino Acids DMEM/F-12, HEPES + NEAA
L-Glutamine 182.50 1.25 Amino Acids DMEM/F-12, HEPES
L-Histidine
hydrochloride-H2O 36.74 0.17 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Isoleucine 79.74 0.61 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Leucine 82.03 0.63 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Lysine hydrochloride 118.63 0.65 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Methionine 23.62 0.16 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Phenylalanine 50.74 0.31 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Proline 20.13 0.18 Amino Acids DMEM/F-12, HEPES + NEAA
L-Serine 44.63 0.43 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES + NEAA
L-Threonine 74.23 0.62 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Tryptophan 12.51 0.06 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Tyrosine disodium salt
dihydrate 79.90 0.31 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
L-Valine 73.43 0.63 Amino Acids
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Biotin 1.75E-03 7.17E-06 Vitamins DMEM/F-12, HEPES
Choline chloride 6.49 0.05 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
D-Calcium pantothenate 3.12 0.01 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Folic Acid 3.33 0.01 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
i-Inositol 9.90 0.06 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Niacinamide 3.01 0.02 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Pyridoxal hydrochloride 2.00 0.01 Vitamins DMEM, high glucose, GlutaMAX™
Pyridoxine
hydrochloride 1.00 4.85E-03 Vitamins DMEM/F-12, HEPES
Riboflavin 0.31 8.23E-04 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Thiamine hydrochloride 3.09 0.01 Vitamins
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Vitamin B12 0.34 2.51E-04 Vitamins DMEM/F-12, HEPES
Calcium Chloride
(CaCl2) (anhyd.) 158.30 1.43
Inorganic
Salts





















(MgSO4) (anhyd.) 73.26 0.61
Inorganic
Salts












DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Sodium Chloride (NaCl) 6697.75 115.48
Inorganic
Salts


















D-Glucose (Dextrose) 3825.50 21.25
Other
Components





Hypoxanthine Na 1.20 0.01
Other
Components DMEM/F-12, HEPES
Linoleic Acid 0.02 7.50E-05
Other
Components DMEM/F-12, HEPES
Lipoic Acid 0.05 2.55E-04
Other
Components DMEM/F-12, HEPES
Phenol Red 11.55 0.03
Other
Components
DMEM, high glucose, GlutaMAX™ +
DMEM/F-12, HEPES
Putrescine 2HCl 0.04 2.52E-04
Other
Components DMEM/F-12, HEPES






Taurine 12.52 0.10 Supplement
B-27™ Supplement
(50X), serum free 1X Supplement
Fetal Bovine Serum 8% (V/V) Supplement
Table S7. Medium formulation for mouse retinal explant culture. Related to Figure 2.
Components
Concentration
(mg/L) mM Category Source
Glycine 26.25 0.35 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Alanine 13.35 0.15 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Arginine hydrochloride 147.50 0.70 Amino Acids DMEM/F-12, HEPES
L-Asparagine 19.80 0.15 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Aspartic acid 19.95 0.15 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Cysteine hydrochloride-H2O 17.56 0.10 Amino Acids DMEM/F-12, HEPES
L-Cystine 2HCl 31.29 0.10 Amino Acids DMEM/F-12, HEPES
L-Glutamic Acid 22.05 0.15 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Glutamine 365.00 2.50 Amino Acids DMEM/F-12, HEPES
L-Histidine hydrochloride-H2O 31.48 0.15 Amino Acids DMEM/F-12, HEPES
L-Isoleucine 54.47 0.42 Amino Acids DMEM/F-12, HEPES
L-Leucine 59.05 0.45 Amino Acids DMEM/F-12, HEPES
L-Lysine hydrochloride 91.25 0.50 Amino Acids DMEM/F-12, HEPES
L-Methionine 17.24 0.12 Amino Acids DMEM/F-12, HEPES
L-Phenylalanine 35.48 0.22 Amino Acids DMEM/F-12, HEPES
L-Proline 28.75 0.25 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Serine 36.75 0.35 Amino Acids
DMEM/F-12, HEPES +
NEAA
L-Threonine 53.45 0.45 Amino Acids DMEM/F-12, HEPES
L-Tryptophan 9.02 0.04 Amino Acids DMEM/F-12, HEPES
L-Tyrosine disodium salt
dihydrate 55.79 0.21 Amino Acids DMEM/F-12, HEPES
L-Valine 52.85 0.45 Amino Acids DMEM/F-12, HEPES
Biotin 3.50E-03 1.43E-05 Vitamins DMEM/F-12, HEPES
Choline chloride 8.98 0.06 Vitamins DMEM/F-12, HEPES
D-Calcium pantothenate 2.24 4.70E-03 Vitamins DMEM/F-12, HEPES
Folic Acid 2.65 0.01 Vitamins DMEM/F-12, HEPES
Niacinamide 2.02 0.02 Vitamins DMEM/F-12, HEPES
Pyridoxine hydrochloride 2.00 0.01 Vitamins DMEM/F-12, HEPES
Riboflavin 0.22 5.82E-04 Vitamins DMEM/F-12, HEPES
Thiamine hydrochloride 2.17 0.01 Vitamins DMEM/F-12, HEPES
Vitamin B12 0.68 5.02E-04 Vitamins DMEM/F-12, HEPES





Cupric sulfate (CuSO4-5H2O) 1.30E-03 5.20E-06
Inorganic
Salts DMEM/F-12, HEPES
Ferric Nitrate (Fe(NO3)3"9H2O) 0.05 1.24E-04
Inorganic
Salts DMEM/F-12, HEPES
Ferrous Sulfate (FeSO4 7H2O) 0.42 1.50E-03
Inorganic
Salts DMEM/F-12, HEPES






Potassium Chloride (KCl) 311.80 4.16
Inorganic
Salts DMEM/F-12, HEPES
Sodium Bicarbonate (NaHCO3) 1200.00 14.29
Inorganic
Salts DMEM/F-12, HEPES











Zinc sulfate (ZnSO4-7H2O) 0.43 1.50E-03
Inorganic
Salts DMEM/F-12, HEPES






Hypoxanthine Na 2.39 0.02
Other
Components DMEM/F-12, HEPES
Linoleic Acid 0.04 1.50E-04
Other
Components DMEM/F-12, HEPES
Lipoic Acid 0.11 5.10E-04
Other
Components DMEM/F-12, HEPES
Phenol Red 8.10 0.02
Other
Components DMEM/F-12, HEPES
Putrescine 2HCl 0.08 5.03E-04
Other
Components DMEM/F-12, HEPES






Taurine 12.52 0.10 Supplement
B-27™ Supplement (50X),
serum free 1X Supplement
Bovine Serum Albumin solution 1% (V/V) Supplement
Table S8. Medium formulation for human retinal explant culture. Related to Figure 3.
Components
Concentration
(mg/L) mM Category Source
Glycine 26.25 0.35 Amino Acids Advanced DMEM/F-12 + NEAA
L-Alanine 13.35 0.15 Amino Acids Advanced DMEM/F-12 + NEAA
L-Arginine hydrochloride 147.50 0.70 Amino Acids Advanced DMEM/F-12
L-Asparagine-H2O 7.50 0.05 Amino Acids Advanced DMEM/F-12
L-Asparagine 19.80 0.15 Amino Acids Advanced DMEM/F-12 + NEAA
L-Aspartic acid 19.95 0.15 Amino Acids Advanced DMEM/F-12 + NEAA
L-Cysteine hydrochloride-
H2O 17.56 0.10 Amino Acids Advanced DMEM/F-12
L-Cystine 2HCl 31.29 0.10 Amino Acids Advanced DMEM/F-12
L-Glutamic Acid 22.05 0.15 Amino Acids Advanced DMEM/F-12 + NEAA
L-Histidine hydrochloride-
H2O 31.48 0.15 Amino Acids Advanced DMEM/F-12
L-Isoleucine 54.47 0.42 Amino Acids Advanced DMEM/F-12
L-Leucine 59.05 0.45 Amino Acids Advanced DMEM/F-12
L-Lysine hydrochloride 91.25 0.50 Amino Acids Advanced DMEM/F-12
L-Methionine 17.24 0.12 Amino Acids Advanced DMEM/F-12
L-Phenylalanine 35.48 0.22 Amino Acids Advanced DMEM/F-12
L-Proline 28.75 0.25 Amino Acids Advanced DMEM/F-12 + NEAA
L-Serine 36.75 0.35 Amino Acids Advanced DMEM/F-12 + NEAA
L-Threonine 53.45 0.45 Amino Acids Advanced DMEM/F-12
L-Tryptophan 9.02 0.04 Amino Acids Advanced DMEM/F-12
L-Tyrosine disodium salt
dihydrate 55.79 0.21 Amino Acids Advanced DMEM/F-12
L-Valine 52.85 0.45 Amino Acids Advanced DMEM/F-12
Ascorbic Acid phosphate 2.50 0.01 Vitamins Advanced DMEM/F-12
Biotin 3.50E-03 1.43E-05 Vitamins Advanced DMEM/F-12
Choline chloride 8.98 0.06 Vitamins Advanced DMEM/F-12
D-Calcium pantothenate 2.24 4.70E-03 Vitamins Advanced DMEM/F-12
Folic Acid 2.65 0.01 Vitamins Advanced DMEM/F-12
Niacinamide 2.02 0.02 Vitamins Advanced DMEM/F-12
Pyridoxine hydrochloride 2.00 0.01 Vitamins Advanced DMEM/F-12
Riboflavin 0.22 5.82E-04 Vitamins Advanced DMEM/F-12
Thiamine hydrochloride 2.17 0.01 Vitamins Advanced DMEM/F-12
Vitamin B12 0.68 5.02E-04 Vitamins Advanced DMEM/F-12
i-Inositol 12.60 0.07 Vitamins Advanced DMEM/F-12
Calcium Chloride (CaCl2)
(anhyd.) 116.60 1.05 Inorganic Salts Advanced DMEM/F-12
Cupric sulfate (CuSO4-
5H2O) 1.30E-03 5.20E-06 Inorganic Salts Advanced DMEM/F-12
Ferric Nitrate
(Fe(NO3)3"9H2O) 0.05 1.24E-04 Inorganic Salts Advanced DMEM/F-12
Ferric sulfate (FeSO4-
7H2O) 0.42 1.50E-03 Inorganic Salts Advanced DMEM/F-12
Magnesium Chloride
(anhydrous) 28.64 0.30 Inorganic Salts Advanced DMEM/F-12
Magnesium Sulfate
(MgSO4) (anhyd.) 48.84 0.41 Inorganic Salts Advanced DMEM/F-12
Potassium Chloride (KCl) 311.80 4.16 Inorganic Salts Advanced DMEM/F-12
Sodium Bicarbonate
(NaHCO3) 2438.00 29.02 Inorganic Salts Advanced DMEM/F-12
Sodium Chloride (NaCl) 6995.50 120.61 Inorganic Salts Advanced DMEM/F-12
Sodium Phosphate dibasic
(Na2HPO4) anhydrous 71.02 0.50 Inorganic Salts Advanced DMEM/F-12
Sodium Phosphate
monobasic (NaH2PO4-
H2O) 62.50 0.45 Inorganic Salts Advanced DMEM/F-12
Zinc sulfate (ZnSO4-7H2O) 0.86 3.00E-03 Inorganic Salts Advanced DMEM/F-12
AlbuMAX® II 400.00 Infinity Proteins Advanced DMEM/F-12
Human Transferrin (Holo) 7.50 Infinity Proteins Advanced DMEM/F-12
Insulin Recombinant Full
Chain 10.00 Infinity Proteins Advanced DMEM/F-12
Glutathione, monosodium 1.00 3.26E-03 Reducing Agents Advanced DMEM/F-12
Ammonium Metavanadate 3.00E-04 2.56E-06 Trace Elements Advanced DMEM/F-12
Manganous Chloride 5.00E-05 2.53E-07 Trace Elements Advanced DMEM/F-12
Sodium Selenite 0.01 2.89E-05 Trace Elements Advanced DMEM/F-12
D-Glucose (Dextrose) 3151.00 17.51 Other Components Advanced DMEM/F-12
Ethanolamine 1.90 0.02 Other Components Advanced DMEM/F-12
Hypoxanthine Na 2.39 0.02 Other Components Advanced DMEM/F-12
Linoleic Acid 0.04 1.50E-04 Other Components Advanced DMEM/F-12
Lipoic Acid 0.11 5.10E-04 Other Components Advanced DMEM/F-12
Phenol Red 8.10 0.02 Other Components Advanced DMEM/F-12
Putrescine 2HCl 0.08 5.03E-04 Other Components Advanced DMEM/F-12
Sodium Pyruvate 110.00 1.00 Other Components Advanced DMEM/F-12
Thymidine 0.37 1.51E-03 Other Components Advanced DMEM/F-12
Taurine 12.52 0.10 Supplement
B-27™ Supplement (50X),
serum free 1X Supplement
Bovine Serum Albumin
solution 1% (V/V) Supplement
CTS™ (Cell Therapy
Systems) N-2 Supplement 1X Supplement
L-Glutamine 292.28 2.00 Supplement
Table S15. Key reagent and resources. Related to Figure 1-4, and Transparent Methods.
Reagent or Media Components Source Identifier
DMEM, high glucose, GlutaMAX™ Supplement [1] Thermo Fisher 10566016
DMEM/F-12, HEPES [1], [2] Thermo Fisher 11330032
B-27™ Supplement (50X), serum free [1], [2], [3] Thermo Fisher 17504044
MEM Non-Essential Amino Acids Solution (100X) (NEAA) [1], [2], [3], [4] Thermo Fisher 11140050
Fetal Bovine Serum [1], [3], [4] Atlanta Biologicals S11550
GlutaMAX™ Supplement [1] Thermo Fisher 35050061
Bovine Serum Albumin solution [2] Sigma-Aldrich A1595-50ML
Taurine [2], [3], [4] Sigma-Aldrich T0625-10G
Advanced DMEM/F-12 [3] Thermo Fisher 12634010
CTS™ (Cell Therapy Systems) N-2 Supplement [3] Thermo Fisher A1370701
L-Glutamine [3] Thermo Fisher 25030081
Minimum Essential Medium Eagle (MEM alpha) [4] Sigma-Aldrich M4526
N1 Medium Supplement (100×) [4] Sigma-Aldrich N6530-5ML
Hydrocortisone [4] Sigma-Aldrich H0888-1G
3, 3', 5-Triiodo-L-Thyronine [4] Sigma-Aldrich T6397-100MG
HBSS, no calcium, no magnesium Thermo Fisher 14170112
Corning® Transwell® polyester membrane cell culture inserts Sigma-Aldrich CLS3470
CO2 Independent Medium Thermo Fisher 18045088
Neurobasal™-A Medium Thermo Fisher 10888022
Biopsy Punch Kai Medical BP-50F, 5.0 mm
Corning® Transwell® polycarbonate membrane cell culture inserts Sigma-Aldrich CLS3421
Mass Spectrometry (GC MS)
Water, Optima™ LC/MS Grade Fisher Chemical 166415
Methanol Fisher Chemical 164905
Methoxyamine hydrochloride Sigma-Aldrich 226904
Pyridine Sigma-Aldrich 270970
N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide Sigma-Aldrich 394882
DB-5ms GC Column, 30 m, 0.25 mm, 0.25 um Agilent
Technologies
1225532
Gel Pump Savant GP110
Speed vac Plus Savant SC110A
Centrifuge Eppendorf 5424
Acquity UPLC BEH Amide 1.7 μm Vanguard pre-column 2.1 x 5mm
column
Waters 186004799
Acquity UPLC BEH Amide 1.7 μm 2.1 x 50mm column Waters 186004800
Acetonitrile, Optima™ LC/MS Grade Fisher Chemical 75-05-8
Ammonium Acetate Sigma-Aldrich 431311
Ammonium hydroxide 28 - 30% in water ACS VWR AC42330-5000
Animals
C57BL/6J Jackson Lab 000664
Nrl knockout mice Anand Swaroop
Lab
[1] Retinal organoid culture medium
[2] Mouse retinal explant culture medium
[3] Human retinal explant culture medium
[4] Human RPE explant culture medium
Table S16. The medium formulation for human RPE/choroid culture. Related to Figure 4.
Components Concentration(mg/L) mM Category Source
Glycine 57.5 0.77 Amino Acids MEM alpha + NEAA
L-Alanine 33.9 0.38 Amino Acids MEM alpha + NEAA
L-Arginine hydrochloride 105.0 0.50 Amino Acids MEM alpha
L-Asparagine-H2O 63.2 0.43 Amino Acids MEM alpha + NEAA
L-Aspartic acid 43.3 0.33 Amino Acids MEM alpha + NEAA
L-Cysteine hydrochloride-
H2O 100.0 0.57 Amino Acids MEM alpha
L-Cystine 2HCl 31.0 0.10 Amino Acids MEM alpha
L-Glutamic Acid 89.8 0.61 Amino Acids MEM alpha + NEAA
L-Glutamine 292.0 2.00 Amino Acids MEM alpha
L-Histidine hydrochloride-
H2O 42.0 0.20 Amino Acids MEM alpha
L-Isoleucine 52.4 0.40 Amino Acids MEM alpha
L-Leucine 52.0 0.40 Amino Acids MEM alpha
L-Lysine hydrochloride 73.0 0.40 Amino Acids MEM alpha
L-Methionine 15.0 0.10 Amino Acids MEM alpha
L-Phenylalanine 32.0 0.19 Amino Acids MEM alpha
L-Proline 51.5 0.45 Amino Acids MEM alpha + NEAA
L-Serine 35.5 0.34 Amino Acids MEM alpha + NEAA
L-Threonine 48.0 0.40 Amino Acids MEM alpha
L-Tryptophan 10.0 0.05 Amino Acids MEM alpha
L-Tyrosine disodium salt 52.0 0.20 Amino Acids MEM alpha
L-Valine 46.0 0.39 Amino Acids MEM alpha
Ascorbic Acid 50.0 0.28 Vitamins MEM alpha
Biotin 1.0E-01 4.00E-04 Vitamins MEM alpha
Choline chloride 1.0 7.10E-03 Vitamins MEM alpha
D-Calcium pantothenate 1.0 2.10E-03 Vitamins MEM alpha
Folic Acid 1.0 2.30E-03 Vitamins MEM alpha
Niacinamide 1.0 8.20E-03 Vitamins MEM alpha
Pyridoxal hydrochloride 1.0 4.90E-03 Vitamins MEM alpha
Riboflavin 1.0E-01 3.00E-04 Vitamins MEM alpha
Thiamine hydrochloride 1.0 3.00E-03 Vitamins MEM alpha
Vitamin B12 1.4 1.00E-03 Vitamins MEM alpha
i-Inositol 2.0 1.11E-02 Vitamins MEM alpha
Calcium Chloride (CaCl2)
(anhyd.) 200.0 1.80 Inorganic Salts MEM alpha
Magnesium Sulfate (MgSO4)
(anhyd.) 97.7 0.81 Inorganic Salts MEM alpha
Potassium Chloride (KCl) 400.0 5.33 Inorganic Salts MEM alpha
Sodium Bicarbonate
(NaHCO3) 2200.0 26.19 Inorganic Salts MEM alpha
Sodium Chloride (NaCl) 6800.0 117.24 Inorganic Salts MEM alpha
Sodium Phosphate
monobasic (NaH2PO4-H2O) 140.0 1.01 Inorganic Salts MEM alpha
D-Glucose (Dextrose) 1000.0 5.56 Other components MEM alpha
Lipoic Acid 0.2 1.00E-03 Other components MEM alpha
Phenol Red 10.0 0.03 Other components MEM alpha
Sodium Pyruvate 110.0 1.00 Other components MEM alpha
Recombinant human insulin 5.0 Other components N1 Supplement
human transferrin 5.0 Other components N1 Supplement
Sodium selenite 5.0E-03 Other components N1 Supplement
Putrescine 16.0 Other components N1 Supplement




Fetal Bovine Serum 1% (V/V) Supplement
Transparent Methods
Reagents
All the reagents and resources are detailed in the Key Resources table (Table S15)
Human retinal organoid culture
Cone-rich human retinal organoids were generated from H1 human embryonic stem cells (WiCell) using a method
described previously (Kim et al., 2019; Lowe et al., 2016). For the assay of metabolite consumption, one retinal organoid
on day 56 or day 296 was grown in a well of a 24-well plate containing 800 µl of culture medium (DMEM/F12 (3:1), 2%
B27, 1x non-essential amino acids (NEAA), 8% fetal bovine serum (FBS), 100 µM Taurine and 2 mM GlutaMAX (see
detail information in Table S6 and Table S15). Culture wells containing 800 µl of the medium without retinal organoids
were used as baseline controls. After 48 hours of culture, 50 µl of the spent medium was collected from each culture well
for metabolite analysis.
Mouse retinal explant culture
Nrl KO mice were generously provided by Anand Swaroop, PhD (National Eye Institute, Bethesda, MD) and were housed
and bred at the West Virginia University Animal Research Facility vivarium. The Nrl KO mice were bred with C57BL6/J
mice purchased from Jackson Laboratories (Bar Harbor, ME) to generate Nrl Het mice which were further bred with Nrl
KO mice. Our studies used littermates at postnatal 36 days with half male and half female. All procedures were in
accordance with the National Institutes of Health guidelines and the protocols approved by the Institutional Animal Care
and Use Committee of West Virginia University. Mouse explant culture was performed as previously reported (Chao et al.,
2017). Briefly, the retina was isolated and made four relief cuts on each side in retinal culture medium containing
DMEM/F12 (3:1), 2% B27, 1x NEAA, 1% FBS, and 100 µM Taurine (detailed in Table S7 and Table S15). The retina was
then transferred into an insert of 24-well transwell plate with photoreceptor-side facing down. The bottom chamber
contained 500 µl and top chamber 100 µl of retinal culture medium. Transwells containing medium without retinas were
cultured as the baseline controls. After 24 hours, 50 µl of the spent medium was collected from the bottom chamber for
metabolite analysis.
Human retina and RPE/choroid explant culture
Post-mortem donor eyes without known eye conditions were obtained from Lions NSW eye bank. Ethical approval for this
project was obtained from the Human Research Ethics Committee of the University of Sydney. The eyes were kept in CO2
independent medium in 4oC until further dissection. All donor eyes within 28 hours post‐mortem (Table S5) were cut open
by removing iris and lens, followed by cutting a circle of the sclera with 0.5cm thickness. Fundus photographs were taken
by a digital microscope camera (Jenoptik Optical System) after the anterior segment was removed. The whole neural
retina was gently detached after separated from the ora serrata and optic nerve head. Then it was bluntly separated from
vitreous and the neural retina was unfolded in a glass petri dish (150mm×15mm) with neurobasal-A medium. 5mm-
diameter circular neural retinas were trephined from the macula and superior mid-peripheral retina using a Biopsy Punch
(Figure 3A). The macula punch was on the fovea. Mid-periphery was defined as the mid-point between the macula lutea
and the ora serrata. RPE-choroid-sclera complexes (RPE/choroid) were trephined from macula and mid-periphery as the
same location in retinal punches. Both retinal and RPE/choroid explants were transferred to the inserts of 24-well
transwell plates (Corning, CLS3421) with culture medium. Neural explants were cultured with photoreceptors facing down,
and RPE-choroid-sclera complexes were cultured with RPE layer facing up to protect the photoreceptor outer segment
and RPE from physical damage (Murali et al., 2019). Retinal culture media was modified from mouse retinal culture
(Table S8 lists detail formulation) and RPE/choroid culture media was the same as we reported (Chao et al., 2017)
(Table S16). The volume of medium for neural explants in the insert is 100µl and in well is 600µl. The volume for RPE
explant is 150µl in insert and 900µl in well. Table 15 listed details for the supplies and culture media. Neural retina and
RPE explants were cultured for 24h at 37°C in 5% CO2 incubator. There was space around tissue explants and the
nutrients can readily exchange between upper chamber and lower chamber. To avoid potential tissue debris in the upper
chamber, we collected 10µl spent medium from the lower chamber for metabolite analysis.
Metabolite analysis
Metabolites were extracted from 10 µl of medium samples, dried with freeze dryer, and analyzed with Liquid
chromatography–mass spectrometry (LC MS) and gas chromatography–mass spectrometry (GC MS) as described (Chao
et al., 2017; Grenell et al., 2019; Yam et al., 2019). LC MS used a Shimadzu LC Nexera X2 UHPLC coupled with a
QTRAP 5500 LC MS (AB Sciex). An ACQUITY UPLC BEH Amide analytic column (2.1 X 50 mm, 1.7 μm, Waters) was
used for chromatographic separation. A total of 190 metabolites were measured with optimal parameters for targeted
metabolomics (Table S1). GC MS used an Agilent 7890B/5977B system with a DB5MS column (30 m × 0.25 mm × 0.25
μm). Mass spectra were collected from 80–600 m/z under selective ion monitoring mode to quantify 28 metabolites (Table
S1). The ion abundance of each metabolite was divided by those from baseline controls to obtain fold changes in
abundance. Metabolite uptake was defined as the significantly changed metabolites with fold changes <-1, and metabolite
release was defined as the significantly changed metabolites with fold changes >1.
Statistics
The significance of differences between means was determined by unpaired or paired two-tailed t tests using GraphPad
Prism 7. The data were presented as mean ± Standard error of mean (SEM). P < 0.05 was considered to be significant.
The differences in metabolic genes were analyzed by Volcano plot using MetaboAnalyst 4.0
(https://www.metaboanalyst.ca/). The changes with fold changes >1.3 and P<0.05 were set as significant.
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